TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Natumin Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 43,925 | 45,205 | 43,901 |
Financial expenses | 343 | 278 | 175 |
Earnings before taxes | -2,671 | -5,845 | -7,418 |
EBITDA | -1,737 | -4,467 | -5,997 |
Total assets | 36,689 | 37,369 | 33,166 |
Current assets | 25,160 | 24,365 | 18,996 |
Current liabilities | 15,522 | 15,039 | 5,591 |
Equity capital | 13,074 | 17,133 | 19,914 |
- share capital | 1,336 | 1,454 | 1,482 |
Employees (average) | 23 | 24 | 25 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 35.6% | 45.8% | 60.0% |
Turnover per employee | 1,910 | 1,884 | 1,756 |
Profit as a percentage of turnover | -6.1% | -12.9% | -16.9% |
Return on assets (ROA) | -6.3% | -14.9% | -21.8% |
Current ratio | 162.1% | 162.0% | 339.8% |
Return on equity (ROE) | -20.4% | -34.1% | -37.3% |
Change turnover | 2,382 | 2,135 | 3,579 |
Change turnover % | 6% | 5% | 9% |
Chg. No. of employees | -1 | -1 | 2 |
Chg. No. of employees % | -4% | -4% | 9% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.